Enter a phrase above to search files and articles within the site.

Typically materials that are more than 5 years old will be archived

Data and Safety Monitoring Boards—PI Responsibilities

https://www.niams.nih.gov/grants-funding/conducting-clinical-research/trial-policies-guidelines-templates/data-safety-monitoring-guidelines-policies/principal-investigator-responsibilities

The clinical study Principal Investigator (PI) safety monitoring responsibilities with respect to a Data and Safety Monitoring Board (DSMB) or Observational Study Monitoring Board (OSMB) ensure the study is conducted according to the highest scientific and ethical standards. Responsibilities are outlined in bold italics.

Osteoarthritis Initiative Application Guide for Biospecimen Studies

https://www.niams.nih.gov/grants-funding/funded-research/osteoarthritis-initiative/osteoarthritis-initiative-application

This document outlines the process by which requests for access to existing biospecimens from the OAI resource are processed, evaluated, and approved. Types of Specimen Available Type of Specimen Maximum Allowable Specimen Per Study Serum 0.15 ml (total of serum and plasma per study) EDTA plasma 0.15 ml (total of